ClinicalTrials.gov record
Approved For Marketing No phase listed Expanded access

Expanded Access for the Treatment of Cancers With Rearranged During Transfection (RET) Activation

ClinicalTrials.gov ID: NCT03906331

Public ClinicalTrials.gov record NCT03906331. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 6:47 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT03906331
Recruitment status
Approved For Marketing
Study type
Expanded access
Phase
Not listed
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
Not listed

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Not listed
Last update posted
Jan 16, 2025

United States locations

U.S. sites
34
U.S. states
16
U.S. cities
31
Facility City State ZIP Site status
Cancer Treatment Centers of America Goodyear Arizona 85338
Mayo Clinic of Scottsdale Scottsdale Arizona 85259
City of Hope National Medical Center Duarte California 91010-0269
UCLA Medical Center Los Angeles California 90095
Kaiser Permanente Oakland California 94612
Irvine Medical Center Orange California 92868
University of California - San Diego San Diego California 92103
Univ of California San Francisco San Francisco California 94115
Kaiser Permanente Santa Clara California 95051
Kaiser Permanente Medical Center Vallejo California 94589
Memorial Cancer Institute Hollywood Florida 33021
Mayo Clinic in Florida Jacksonville Florida 32224
Florida Hospital Orlando Florida 32803
Tallahassee Memorial Cancer Center Tallahassee Florida 32308
University Cancer and Blood Center Athens Georgia 30607
Emory University Atlanta Georgia 30329-5102
University of Chicago Medicine-Comprehensive Cancer Center Chicago Illinois 60637
Cancer Treatment Centers of America Zion Illinois 60099
Massachusetts General Hospital Boston Massachusetts 02114
Dana-Farber Cancer Institute Boston Massachusetts 02215
University of Michigan Ann Arbor Michigan 48109
START Midwest Grand Rapids Michigan 49546
Mayo Clinic Rochester Minnesota 55905
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89169
Memorial Sloan Kettering Cancer Center New York New York 10065
Cleveland Clinic Foundation Cleveland Ohio 44195
Ohio State University Medical Center Columbus Ohio 43210
Cancer Treatment Centers of America Tulsa Oklahoma 74133
University of Pennsylvania Hospital Philadelphia Pennsylvania 19104
Eastern Regional Medical Center Philadelphia Pennsylvania 19124
Oncology Consultants Houston Texas 77030
University of Texas MD Anderson Cancer Center Houston Texas 77030
Virginia Cancer Specialists Fairfax Virginia 22031
University of Wisconsin-Madison Hospital and Health Clinic Madison Wisconsin 53792-4108

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 30 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03906331, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 16, 2025 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03906331 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →